Fresenius Medical Care AG (ETR:FME)
Germany · Delayed Price · Currency is EUR 39.18
+0.73 (1.90%)
Oct 22, 2026, 5:35 PM CEST
Fresenius Medical Care AG Revenue
Fresenius Medical Care AG had revenue of 4.86B EUR in the quarter ending June 30, 2026, with 1.44% growth. This brings the company's total for the last twelve months to 19.43B, down -0.47% year-over-year. In the year 2025, Fresenius Medical Care AG had annual revenue of 19.63B with 1.51% growth. That makes Fresenius Medical Care AG the 687th largest company in the world by revenue and 38th in Germany.
Revenue (ttm)
19.43B
Revenue Growth
-0.47%
P/S Ratio
0.52
Revenue / Employee
181.18K
Employees
107,226
Market Cap
10.38B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Fresenius Medical Care AG breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.63B | 291.69M | 1.51% |
| Dec 31, 2024 | 19.34B | -117.71M | -0.61% |
| Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
| Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
| Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
| Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
| Dec 31, 2019 | 17.48B | 929.68M | 5.62% |
| Dec 31, 2018 | 16.55B | -1.24B | -6.95% |
| Dec 31, 2017 | 17.78B | 1.21B | 7.33% |
| Dec 31, 2016 | 16.57B | 1.16B | 7.49% |
| Dec 31, 2015 | 15.41B | 2.33B | 17.81% |
| Dec 31, 2014 | 13.08B | 2.46B | 23.16% |
| Dec 31, 2013 | 10.62B | 162.03M | 1.55% |
| Dec 31, 2012 | 10.46B | 751.40M | 7.74% |
| Dec 31, 2011 | 9.71B | 851.63M | 9.61% |
| Dec 31, 2010 | 8.86B | 1.01B | 12.94% |
| Dec 31, 2009 | 7.84B | 229.27M | 3.01% |
| Dec 31, 2008 | 7.61B | 964.95M | 14.51% |
| Dec 31, 2007 | 6.65B | 190.66M | 2.95% |
| Dec 31, 2006 | 6.46B | 728.04M | 12.70% |
| Dec 31, 2005 | 5.73B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Sartorius Aktiengesellschaft | 3.58B |
| Redcare Pharmacy NV | 3.22B |
| Fielmann Group AG | 2.46B |
| Carl Zeiss Meditec AG | 2.18B |
Fresenius Medical Care AG News
- 1 day ago - Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™ - PRNewsWire
- 2 days ago - Investors unlikely to find positive Fresenius take from HHS plan, says JPMorgan - TheFly
- 3 days ago - EQS-DD: Fresenius Medical Care AG: Martin Fischer, Acquisition of shares under the Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Allocation 2023) - Wallstreet:Online
- 3 days ago - Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026 - PRNewsWire
- 10 days ago - Fresenius Medical price target lowered to $24 from $25 at Truist - TheFly
- 14 days ago - Fresenius Medical Care Names Shervin Korangy CEO - Nasdaq
- 14 days ago - Fresenius Medical Care AG (FMS) Shares Fall 7.7% -- What GF Score of 74 Tells Investors - GuruFocus
- 15 days ago - Fresenius Medical Care (FMS) Names Shervin Korangy as New CEO and Chair - GuruFocus